Skip to content

Amber’s platform roadmap is focused on expanding treatment possibilities for defined vertebral fracture segments where restoration, stabilization, and motion preservation matter. Future development priorities include physician-directed cement strategies, compatibility with posterior fixation workflows, and evidence generation to clarify patient selection and clinical value.

VCFix spinal system pedicle screw for vertebral reconstruction

VCFix Standalone

We are currently clinically investigating the VCFix® implant as a standalone device for treating vertebral fractures. (See EXPAND trial for more information.) 

The goal is to validate that the mechanical strength of the VCFix implant is sufficient to be used without cement. This may reduce procedure time and avoid any risk related to cement leakage.

VCFix™ Spinal System for vertebral compression fracture

Compatibility with Posterior Fixation

We are currently developing products that make VCFix® compatible with both short and long-segment posterior fixation. This design feature enables the treatment of incomplete burst fractures through single-level fixation located cranial to the fracture, thereby preserving an intact mobile segment that would otherwise need immobilization.
VCFix™ Spinal System for vertebral compression fracture

Compatibility with posterior fixation

We are currently developing products that make VCFix® compatible with both short and long-segment posterior fixation. This design feature enables the treatment of incomplete burst fractures through single-level fixation located cranial to the fracture, thereby preserving an intact mobile segment that would otherwise need immobilization.

VCFix® System Pipeline

2025
EXPAND Trial Launch

Validate the compatibility of VCFix® Spinal System with posterior fixation and as a standalone system. (See EXPAND for more information.)

2026
VCFix® Spinal System launch in US

Introduce VCFix® Spinal System with cement to the U.S. market.

2027
VCFix® as Adjunct to Posterior Fixation Systems

Expand indications with U.S. and European regulatory agencies to include VCFix® Spinal System for use with select posterior fixation systems and VCFix® for use with Amber Implants’ own Spinoza® Fixation System.

2028
VCFix® Spinal System without Cement

Expand indications with U.S. and European regulatory agencies to include VCFix® Spinal System as a standalone device (with or without bone cement).

2027-2028
VCFix Stand Alone

Planned submissions to obtain FDA and CE marking for the label expansion of  VCFix stand-alone.